Grace Therapeutics Inc. (GRCE) Statistics & Valuation Metrics - Stocknear

Grace Therapeutics Inc.

NASDAQ: GRCE · Real-Time Price · USD
3.20
0.14 (4.58%)
At close: Sep 05, 2025, 3:59 PM
3.26
1.87%
After-hours: Sep 05, 2025, 04:53 PM EDT

Grace Therapeutics Statistics

Share Statistics

Grace Therapeutics has 13.83M shares outstanding. The number of shares has increased by null% in one year.

13.83M
n/a
n/a
34.97%
n/a
3,131
4.17%

Short Selling Information

The latest short interest is 80.17K, so 0.58% of the outstanding shares have been sold short.

80.17K
0.58%
0.7%
1

Valuation Ratios

The PE ratio is -2.16 and the forward PE ratio is -3.36. Grace Therapeutics's PEG ratio is 0.04.

-2.16
-3.36
0
98.3
0.41
-1.85
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Grace Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 11.77, with a Debt / Equity ratio of 0.

11.77
11.77
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-3.19M
4
0
n/a

Taxes

-3.2M
25.06%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.06, so Grace Therapeutics's price volatility has been higher than the market average.

1.06
n/a
3.13
3.08
54.22
75,140

Income Statement

n/a
-7K
-16.68M
-12.77M
-12.76M
-12.77M
-0.79
Full Income Statement

Balance Sheet

The company has 22.13M in cash and 0 in debt, giving a net cash position of 22.13M.

22.13M
n/a
n/a
-220.69M
69.81M
18.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.9M and capital expenditures 0, giving a free cash flow of -14.9M.

-14.9M
n/a
-14.9M
-1.23
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for GRCE is $12, which is 275% higher than the current price. The consensus rating is "Buy".

$12
275%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jul 10, 2023. It was a backward split with a ratio of 1:6.

Jul 10, 2023
backward
1:6

Scores

-0.95
2